Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Cancer survivors need better skin care to improve their quality of life.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Decomposed tritiated thymidine is less accurate for DNA tracing, and hair changes can indicate malnutrition.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Geranium sibiricum extract helps hair grow and is more effective than minoxidil but can be toxic in high concentrations.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Tamoxifen caused hair loss in a 52-year-old woman.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Chemicals from the plant Dicerocaryum senecioides were found to safely speed up and increase hair growth in mice.

Higher DHT in male baldness may protect against prostate cancer.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Platelet-rich fibrin helps heal stubborn wounds in rats by reducing inflammation and boosting tissue repair.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

MSF-VMDNet accurately segments skin cancer images better than existing methods.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.